Erratum: Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment (PLoS ONE (2015) 4:7 (e6157) DOI: 10.1371/journal.pone.0006157);Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Fricke, Stephan ^a,b   Ackermann, Manuela ^b   Stolzing, Alexandra ^a   Schimmelpfennig, Christoph ^a   Hilger, Nadja ^a   Jahns, Jutta ^b   Hildebrandt, Guido ^c   Emmrich, Frank ^a,b   Ruschpler, Peter ^a   Pösel, Claudia ^a   Kamprad, Manja ^a,b   Sack, Ulrich ^a,b  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; LEUKOCYTE ANTIGEN;

ALLOGENEIC NON ADEHERENT BONE MARROW CELL TRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; CULTURE MEDIUM; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; SYNGENEIC NON ADEHERENT BONE MARROW CELL TRANSPLANTATION; X IRRADIATION; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CELL ADHESION; CELL DIVISION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; TRANSGENIC MOUSE;

MURINAE; MUS; MUS MUSCULUS;

ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL DIVISION; CULTURE MEDIA; FLOW CYTOMETRY; IMMUNOPHENOTYPING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 67650234481     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136005     Document Type: Erratum

References (38)

1. Shlomchik WD (2007) Graft-versus-host disease. Nat Rev Immunol 7: 340-352.
2. Aschan J (2006) Allogeneic haematopoietic stem cell transplantation: current status and future outlook. Br Med Bull 77-78: 23-36.
3. Bacigalupo A, Frassoni F, Van Lint MT (2002) Bone marrow or peripheral blood as a source of stem cells for allogeneic transplantation. Haematologica 87: 4-8.
4. Kestendjieva S, Kyurkchiev D, Tsvetkova G, Mehandjiev T, Dimitrov A, et al. (2008) Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int 32: 724-732.
5. Ferrara JL (2007) Novel strategies for the treatment and diagnosis of graft-versus-host-disease. Best Pract Res Clin Haematol 20: 91-97.
6. Tamura K, Drew R (2008) Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients. Drugs Today (Barc) 44: 515-530.
7. Ho VT, Revta C, Richardson PG (2008) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant 41: 229-237.
8. Handgretinger R, Lang P (2008) The history and future prospective of haplo-identical stem cell transplantation. Cytotherapy 10: 443-451.
9. Martino R, Martin-Henao G, Sureda A, Altes A, Canals C, et al. (2000) Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study. Haematologica 85: 1165-1171.
10. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, et al. (2007) Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110: 2764-2767.
11. Ma LJ, Hu XX, Zhou H, Gao L, Xie LN, et al. (2008) [Study on hematopoiesis reconstitution by co-transplant of human bone marrow mesenchymal stem cells and umbilical cord blood CD34(+) cells at different ratios in NOD/SCID mice]. Zhonghua Xue Ye Xue Za Zhi 29: 684-688.
12. Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28: 875-884.
13. Zhu GR, Zhou XY, Lu H, Zhou JW, Li AP, et al. (2003) [Human bone marrow mesenchymal stem cells express multiple hematopoietic growth factors]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 11: 115-119.
14. Stagg J, Galipeau J (2007) Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb Exp Pharmacol:45-66.
15. Javazon EH, Beggs KJ, Flake AW (2004) Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32: 414-425.
16. Friedenstein AJ, Latzinik NV, Gorskaya Y, Luria EA, Moskvina IL (1992) Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner 18: 199-213.
17. Rickard DJ, Kazhdan I, Leboy PS (1995) Importance of 1,25-dihydroxyvitamin D3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone 16: 671-678.
18. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
19. Tokcaer-Keskin Z, Akar AR, yaloglu-Butun F, Terzioglu-Kara E, Durdu S, et al. (2009) Timing of induction of cardiomyocyte differentiation for in vitro cultured mesenchymal stem cells: a perspective for emergencies. Can J Physiol Pharmacol 87: 143-150.
20. Zhang ZL, Tong J, Lu RN, Scutt AM, Goltzman D, et al. (2008) Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration. Bone Marrow Transplant.
21. Clarke E, McCann SR (1991) Stromal colonies can be grown from the non-adherent cells in human long-term bone marrow cultures. Eur J Haematol 46: 296-300.
22. Scutt A, Zeschnigk M, Bertram P (1995) PGE2 induces the transition from non-adherent to adherent bone marrow mesenchymal precursor cells via a cAMP/EP2-mediated mechanism. Prostaglandins 49: 383-395.
23. Ferrari G, Cusella-De AG, Coletta M, Paolucci E, Stornaiuolo A, et al. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 1528-1530.
24. Wlodarski KH, Galus R, Wlodarski P (2004) Non-adherent bone marrow cells are a rich source of cells forming bone in vivo. Folia Biol (Praha) 50: 167-173.
25. Laub R, Dorsch M, Meyer D, Ermann J, Hedrich HJ, et al. (2000) A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses. J Immunol Methods 246: 37-50.
26. Laub R, Dorsch M, Wenk K, Emmrich F (2001) Induction of immunologic tolerance to tetanus toxoid by anti-human CD4 in HLA-DR3(+)/human CD4(+)/ murine CD4(-) multiple transgenic mice. Transplant Proc 33: 2182-2183.
27. Cooke KR, Hill GR, Crawford JM, Bungard D, Brinson YS, et al. (1998) Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 102: 1882-1891.
28. Spargo LD, Cleland LG, Cockshell MP, Mayrhofer G (2006) Recruitment and proliferation of CD4+ T cells in synovium following adoptive transfer of adjuvant-induced arthritis. Int Immunol 18: 897-910.
29. Sprangers B, Van WB, Luyckx A, Sagaert X, De SL, et al. (2008) Allogeneic bone marrow transplantation and donor lymphocyte infusion in a mouse model of irradiation-induced myelodysplastic/myeloproliferation syndrome (MD/MPS): evidence for a graft-versus-MD/MPS effect. Leukemia.
30. de RT, Appelbaum FR, Storb R, Schuening F, Nash R, et al. (1994) Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83: 3795-3799.
31. MacVittie TJ, Farese AM, Jackson W III (2005) Defining the full therapeutic potential of recombinant growth factors in the post radiation-accident environment: the effect of supportive care plus administration of G-CSF. Health Phys 89: 546-555.
32. Kim JY, Oh SJ, Park HK, Yoon JS, Kim ES, et al. (2005) Radioprotective effects of various cytokines in peripheral blood mononuclear cells and C3H mice. Oncol Rep 13: 1177-1183.
33. Epperly MW, Cao S, Goff J, Shields D, Zhou S, et al. (2005) Increased longevity of hematopoiesis in continuous bone marrow cultures and adipocytogenesis in marrow stromal cells derived from Smad3(-/-) mice. Exp Hematol 33: 353-362.
34. Thalmeier K, Huss R (2001) Highly efficient retroviral gene transfer into immortalized CD34(-) cells and organ distribution after transplantation into NOD/SCID mice. Cytotherapy 3: 245-251.
35. in 't Anker PS, Noort WA, Kruisselbrink AB, Scherjon SA, Beekhuizen W, et al. (2003) Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 31: 881-889.
36. Laub R, Dorsch M, Wedekind D, Meyer D, Schroder S, et al. (1999) Replacement of murine by human CD4 and introduction of HLA-DR17 in mice: A triple-transgenic animal model to study human MHC II-CD4 interaction in situ. Journal of Experimental Animal Science 39: 122-135.
37. Dobson KR, Reading L, Haberey M, Marine X, Scutt A (1999) Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif Tissue Int 65: 411-413.
38. Tschetter JR, Mozes E, Shearer GM (2000) Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J Immunol 165: 5987-5994.